Taysha Gene Therapies, Inc. TSHA
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Jack Allen | Robert W. Baird | 4.765 $ | 12 $ | 7.24 % | 02/10/2025 |
| Gil Blum | Needham | 4.765 $ | 10 $ | 5.24 % | 02/10/2025 |
| Keith Tapper | BMO Capital | 2.31 $ | 5 $ | 2.69 % | 14/08/2024 |
| Christopher Raymond | Piper Sandler | 2.24 $ | 7 $ | 4.76 % | 01/07/2024 |
| Eun Yang | Jefferies | 2.4 $ | 8 $ | 5.60 % | 14/05/2024 |
| Christopher Raymond | Raymond James | 2.68 $ | 9 $ | 6.32 % | 09/04/2024 |
| Matthew Harrison | Morgan Stanley | 17.63 $ | 39 $ | 21.37 % | 19/10/2021 |
| Kristen Kluska | Cantor Fitzgerald | 21.78 $ | 44 $ | 22.22 % | 19/05/2021 |